|Articles|February 1, 2002

February 2002
Volume 8
Issue 2

Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

Author(s)Sara Rosenbaum, JD, D. Richard Mauery, MPH, Joel Teitelbaum, LLM

Download PDF: Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

Articles in this issue

over 24 years ago

Article

"Trial" Prescriptions to Reduce Drug Wastage: Results From Canadian Programs and a Community Demonstration Project

over 24 years ago

Article

Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

over 24 years ago

Article

Comparison of Two Systems for Clinical Practice Profiling in Diabetic Care: Medical Records Versus Claims and Administrative Data

over 24 years ago

Article

A Comparison of Ambulatory Services for Patients with Managed Care and Fee-for-Service Insurance

over 24 years ago

Article

A New Method for Determining Patient Payments for Outpatient Drugs

over 24 years ago

Article

Expanded Use of Nurse Practitioners

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

MDS/MPN Response Criteria Tied to Survival

ICER Draft Flags High Cost of New Hypertension Drug Class